marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2022-Q2
hinzugefügt 08.08.2022
Global Blood Therapeutics Bilanz 2011-2024 | GBT
Bilanz Jährlich Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-433 M | -262 M | 79.1 M | -275 M | -198 M | -92.1 M | -149 M | -52.1 M | -3.28 M | - | - |
Langfristige Schulden |
246 M | 149 M | 73.6 M | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
5.67 M | 4.84 M | 1.87 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | 229 M | 146 M | 11.1 M | 11.7 M | 563 K | 1.56 M | 103 M | 28.4 M | - | - |
Kurzfristige Verbindlichkeiten |
88 M | 79 M | 71.5 M | 33.8 M | 26.3 M | 15.5 M | 10.7 M | - | - | - | - |
Gesamtverbindlichkeiten |
743 M | 308 M | 217 M | 44.8 M | 37.9 M | 16.1 M | 12.3 M | 105 M | 32.1 M | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-1.29 B | -986 M | -739 M | -472 M | -298 M | -181 M | -98.5 M | -49.3 M | -28 M | - | - |
Vermögenswerte |
939 M | 724 M | 796 M | 618 M | 357 M | 202 M | 153 M | 55.8 M | 6.17 M | - | - |
Zahlungsmittel |
685 M | 495 M | 302 M | 275 M | 198 M | 92.1 M | 149 M | 52.1 M | 3.28 M | - | - |
Buchwert |
196 M | 416 M | 579 M | 573 M | 319 M | 186 M | 141 M | -49.3 M | -26 M | - | - |
Gesamtes Eigenkapital |
196 M | 416 M | 579 M | 573 M | 319 M | 186 M | 141 M | -49.3 M | -26 M | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Global Blood Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | 247 M | 247 M | 246 M | 150 M | 149 M | 149 M | 149 M | 149 M | 149 M | 149 M | 73.6 M | 73.6 M | 73.6 M | 73.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
- | - | 752 M | 736 M | 743 M | 299 M | 299 M | 287 M | 308 M | 308 M | 308 M | 308 M | 217 M | 217 M | 217 M | 217 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 37.9 M | 37.9 M | 37.9 M | 37.9 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 11.2 M | 12.3 M | 12.3 M | 12.3 M | 2.92 M | 2.92 M | 2.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
- | - | -1.45 B | -1.37 B | -1.29 B | -1.2 B | -1.13 B | -1.06 B | -986 M | -986 M | -986 M | -986 M | -739 M | -739 M | -739 M | -739 M | -472 M | -472 M | -472 M | -472 M | -298 M | -298 M | -298 M | -298 M | -181 M | -181 M | -181 M | -181 M | -98.5 M | -98.5 M | -98.5 M | -98.5 M | -49.3 M | -49.3 M | -49.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
- | - | 870 M | 870 M | 939 M | 608 M | 615 M | 650 M | 724 M | 724 M | 724 M | 724 M | 796 M | 796 M | 796 M | 796 M | 618 M | 618 M | 618 M | 618 M | 357 M | 357 M | 357 M | 357 M | 202 M | 202 M | 202 M | 202 M | 152 M | 153 M | 153 M | 153 M | 55.8 M | 55.8 M | 55.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
- | - | 261 M | 392 M | 685 M | 383 M | 419 M | 445 M | 497 M | 495 M | 495 M | 495 M | 302 M | 302 M | 302 M | 302 M | 275 M | 275 M | 275 M | 275 M | 198 M | 198 M | 198 M | 198 M | 92.1 M | 92.1 M | 92.1 M | 92.1 M | 149 M | 149 M | 149 M | 149 M | 52.1 M | 52.1 M | 52.1 M | - | 3.28 M | - | - | - | 3.64 M | - | - | - | - | - | - | - |
Buchwert |
- | - | 118 M | 134 M | 196 M | 308 M | 316 M | 363 M | 416 M | 416 M | 416 M | 416 M | 579 M | 579 M | 579 M | 579 M | 573 M | 573 M | 573 M | 573 M | 319 M | 319 M | 319 M | 319 M | 186 M | 186 M | 186 M | 186 M | 141 M | 141 M | 141 M | 141 M | 52.8 M | 52.8 M | 52.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
- | - | 118 M | 134 M | 196 M | 308 M | 316 M | 363 M | 416 M | 416 M | 416 M | 416 M | 579 M | 579 M | 579 M | 579 M | 573 M | 573 M | 573 M | 573 M | 319 M | 319 M | 319 M | 319 M | 186 M | 186 M | 186 M | 186 M | 141 M | 141 M | 141 M | 141 M | -49.3 M | -49.3 M | -49.3 M | - | -26 M | - | - | - | -9.35 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung